Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma
Open Access
- 1 October 2007
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 9 (4), 412-423
- https://doi.org/10.1215/15228517-2007-024
Abstract
Angiogenesis inhibitors appear to be promising therapies for highly vascularized tumors such as glioblastoma multiforme (GBM). Sunitinib is an oral mKeywords
This publication has 43 references indexed in Scilit:
- Safety, Pharmacokinetic, and Antitumor Activity of SU11248, a Novel Oral Multitarget Tyrosine Kinase Inhibitor, in Patients With CancerJournal of Clinical Oncology, 2006
- Genetic and hypoxic regulation of angiogenesis in gliomasJournal of Neuro-Oncology, 2004
- Antiangiogenic Therapy Against Experimental Glioblastoma Using Genetically Engineered Cells Producing Interferon-α, Angiostatin, or EndostatinHuman Gene Therapy, 2003
- Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivoInternational Journal of Cancer, 2003
- Invasion of human glioma biopsy specimens in cultures of rodent brain slices: a quantitative analysisJournal of Neurosurgery, 2002
- Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2.2001
- Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase.1999
- Local invasion and intraparenchymal metastasis, of astrocytomasNeuropathology and Applied Neurobiology, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas.1992